MAZZIOTTI, Gherardo
 Distribuzione geografica
Continente #
NA - Nord America 3.487
EU - Europa 1.408
AS - Asia 608
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
AF - Africa 3
SA - Sud America 3
Totale 5.520
Nazione #
US - Stati Uniti d'America 3.475
CN - Cina 423
UA - Ucraina 415
PL - Polonia 348
DE - Germania 210
FI - Finlandia 127
HK - Hong Kong 120
IT - Italia 79
IE - Irlanda 63
GB - Regno Unito 62
FR - Francia 61
IN - India 25
SG - Singapore 15
RU - Federazione Russa 14
VN - Vietnam 12
CA - Canada 11
SE - Svezia 10
BE - Belgio 8
EU - Europa 7
IR - Iran 6
AU - Australia 4
NL - Olanda 4
ES - Italia 2
JP - Giappone 2
MA - Marocco 2
RO - Romania 2
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
KR - Corea 1
MU - Mauritius 1
MX - Messico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 5.520
Città #
Fairfield 644
Warsaw 347
Houston 341
Ashburn 335
Woodbridge 316
Jacksonville 290
Seattle 246
Cambridge 234
Ann Arbor 215
Wilmington 198
Chandler 124
Hong Kong 120
Princeton 118
Nanjing 103
Beijing 98
Helsinki 72
New York 67
Dublin 63
Nanchang 51
Des Moines 32
San Diego 30
Shenyang 30
Brescia 24
Jiaxing 20
Changsha 19
Shanghai 19
Hebei 16
Washington 16
Milan 15
Tianjin 13
Dong Ket 12
Kunming 12
Dalmine 10
Hangzhou 10
Toronto 10
Augusta 9
Brussels 8
San Francisco 8
San Mateo 8
Cassina de' Pecchi 7
London 7
Los Angeles 7
Greifswald 6
Lancaster 6
Leawood 6
Mumbai 6
Boardman 5
Jinan 5
Monmouth Junction 5
Ardabil 4
Dearborn 4
Haikou 4
Ningbo 4
Redwood City 4
Verona 4
Falls Church 3
Genoa 3
Lanzhou 3
New Bedfont 3
Nürnberg 3
Bangalore 2
Fuzhou 2
Kilburn 2
Lappeenranta 2
Napoli 2
Phoenix 2
Rabat 2
Taizhou 2
Tokyo 2
Zhengzhou 2
Almere Stad 1
Bratislava 1
Bucharest 1
Calcinato 1
Calonne-sur-la-Lys 1
Canberra 1
Castegnato 1
Changchun 1
Charlotte 1
Chicago 1
Chiswick 1
Copenhagen 1
Falkenstein 1
Ferrara 1
Frankfurt am Main 1
Guangzhou 1
Gunzenhausen 1
Huntington 1
Jakarta 1
Krasnoyarsk 1
Ma'anshan 1
Madrid 1
Melbourne 1
Mexico City 1
Nanuet 1
Nave 1
Norwalk 1
Orange 1
Perth 1
Piscataway 1
Totale 4.452
Nome #
Elevated intraocular pressure in patients with acromegaly 265
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 242
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 144
Growth hormone deficiency in treated acromegaly 131
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 128
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 117
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 113
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 113
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 110
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 108
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 107
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 103
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 102
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 96
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 95
Octreotide for acromegaly treatment: a reappraisal. 94
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 94
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 93
Prevalence of vertebral fractures in men with acromegaly 92
Glucocorticoids and the regulation of growth hormone secretion. 92
Cardiovascular risk in aging and obesity: is there a role for GH. 92
New understanding and treatments for osteoporosis. 91
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 90
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 90
Vertebral fractures in males with prolactinoma. 90
Growth hormone deficiency in the adult. 89
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 89
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 89
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 89
Pituitary diseases and bone 88
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 86
Growth hormone replacement therapy and fracture risk 86
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. 86
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. 85
Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus. 85
Meta-analysis on the effects of octreotide on tumor mass in acromegaly. 83
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 83
Cushing's syndrome and bone. 79
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. 79
Glucocorticoid-induced osteoporosis: an update. 78
Growth hormone, insulin like growth factors, and the skeleton 78
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 77
Glucocorticoid-induced osteoporosis: pathophysiology and therapy. 77
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 77
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field? 76
Resistance to somatostatin analogs in acromegaly: an evolving concept? 74
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. 73
Subclinical thyrotoxicosis and bone 71
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma 68
Commentary:Postsurgical monitoring of acromegaly 67
GH deficiency in the adult and bone. 62
Glucocorticoid-induced osteoporosis and parathyroid hormone. 59
Glucocorticoid replancement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 57
Drug-induced osteoporosis:mechanism and clinical implications 55
Prevention and treatment of glucocorticoid-induced osteoporosis. 53
Diagnosis and treatment of acromegaly and its complications: consensus guidelines. 53
Osteoporosis in HIV patients: an emerging clinical issue 51
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 51
Growth Hormone Insuline like Growth Factor-1, and the Kidney Pathophysiological and Clinical Implication 37
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 36
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 21
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 21
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 20
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 19
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 17
null 13
null 11
null 8
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 8
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 7
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 6
null 5
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors (Journal of Endocrinological Investigation, (2023), 10.1007/s40618-023-02174-5) 2
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 2
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 1
Totale 5.579
Categoria #
all - tutte 22.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019367 0 0 0 0 0 0 0 0 0 0 199 168
2019/20201.744 251 62 83 236 117 175 149 194 144 160 79 94
2020/2021999 16 118 25 107 47 98 56 107 124 123 150 28
2021/2022511 43 105 10 15 5 25 26 32 23 54 39 134
2022/2023401 69 2 2 22 48 119 1 32 66 2 16 22
2023/2024512 28 15 45 59 44 114 28 17 151 7 4 0
Totale 5.579